We are live on !
Find out more
Fairscale Capital Portfolio holdings
AUM
$167M
Turnover
2.25%
1-Year Est. Return
28.67%
This Fund
S&P 500
This Quarter Est. Return
+18.51%
1 Year Est. Return
+28.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$167M
AUM Growth
+$22.8M
(+16%)
Cap. Flow
+$1.04M
Cap. Flow % of AUM
Cap. Flow %
0.62%
Top 10 Holdings %
Top 10 Hldgs %
52.44%
Holding
444
New
7
Increased
24
Reduced
43
Closed
3
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$566K |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$297K |
| 3 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$297K |
| 4 |
Vanguard High Dividend Yield ETF
VYM
|
+$219K |
| 5 |
Calamos S&P 500 Structured Alt Protection ETF - June
CPSU
|
+$199K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$222K |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$126K |
| 3 |
NVIDIA
NVDA
|
+$118K |
| 4 |
Freeport-McMoran
FCX
|
+$107K |
| 5 |
Synopsys
SNPS
|
+$101K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.24% |
| 2 | Technology | 20.89% |
| 3 | Financials | 6.18% |
| 4 | Communication Services | 6% |
| 5 | Consumer Discretionary | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Symbotic
SYM
$5.06B
| $4.54K | ﹤0.01% |
101
| – | – |
2024 Q2
8 quarters
|
|
352
CVS Health
CVS
$115B
| $4.04K | ﹤0.01% |
39
| – | – |
2024 Q2
8 quarters
|
|
|
353
Synopsys
SNPS
$92.3B
| $4.02K | ﹤0.01% |
9
-214
| -96% | -$101K |
2024 Q2
8 quarters
|
|
354
Insmed
INSM
$21.2B
| $3.94K | ﹤0.01% |
37
| – | – |
2025 Q2
4 quarters
|
|
355
Vanguard Energy ETF
VDE
$11.5B
| $3.75K | ﹤0.01% |
25
| – | – |
2026 Q1
1 quarter
|
|
356
iShares MSCI USA Quality Factor ETF
QUAL
$48.3B
| $3.73K | ﹤0.01% |
17
| – | – |
2025 Q4
2 quarters
|
|
357
IsoEnergy Ltd
ISOU
$593M
| $3.73K | ﹤0.01% |
374
| – | – |
2025 Q2
4 quarters
|
|
358
Celsius Holdings
CELH
$7.08B
| $3.72K | ﹤0.01% |
127
| – | – |
2024 Q4
6 quarters
|
|
359
Skyworks Solutions
SWKS
$20.5B
| $3.66K | ﹤0.01% |
54
| – | – |
2024 Q2
8 quarters
|
|
360
Millrose Properties Inc
MRP
$4.21B
| $3.64K | ﹤0.01% |
121
| – | – |
2025 Q2
4 quarters
|
|
361
The Magnum Ice Cream Company N.V.
MICC
$11.7B
| $3.62K | ﹤0.01% |
208
| – | – |
2025 Q4
2 quarters
|
|
362
Carvana
CVNA
$65B
| $3.62K | ﹤0.01% |
55
| – | – |
2025 Q2
4 quarters
|
|
363
Omnicom Group
OMC
$21.3B
| $3.61K | ﹤0.01% |
49
| – | – |
2024 Q2
8 quarters
|
|
364
iShares Core MSCI Emerging Markets ETF
IEMG
$152B
| $3.48K | ﹤0.01% |
42
| – | – |
2025 Q4
2 quarters
|
|
365
Five Point Holdings
FPH
$294M
| $3.27K | ﹤0.01% |
621
| – | – |
2025 Q2
4 quarters
|
|
366
Edwards Lifesciences
EW
$52.9B
| $3.26K | ﹤0.01% |
36
| – | – |
2025 Q2
4 quarters
|
|
367
Celanese
CE
$5.36B
| $3.22K | ﹤0.01% |
70
| – | – |
2024 Q2
8 quarters
|
|
368
CRISPR Therapeutics
CRSP
$5.23B
| $3.22K | ﹤0.01% |
59
| – | – |
2024 Q2
8 quarters
|
|
369
Itron
ITRI
$4.06B
| $3.2K | ﹤0.01% |
37
| – | – |
2024 Q2
8 quarters
|
|
370
PayPal
PYPL
$47.3B
| $3.15K | ﹤0.01% |
73
| – | – |
2024 Q2
8 quarters
|
|
371
VanEck Social Sentiment ETF
BUZZ
$94.5M
| $3.07K | ﹤0.01% |
83
| – | – |
2024 Q2
8 quarters
|
|
372
GoodRx Holdings
GDRX
$1.18B
| $3.05K | ﹤0.01% |
1,060
| – | – |
2025 Q4
2 quarters
|
|
373
Lithium Americas
LAC
$788M
| $3.05K | ﹤0.01% |
792
| – | – |
2024 Q2
8 quarters
|
|
374
Ecolab
ECL
$82B
| $2.79K | ﹤0.01% |
10
| – | – |
2024 Q2
8 quarters
|
|
375
Elevance Health
ELV
$89.9B
| $2.71K | ﹤0.01% |
7
| – | – |
2024 Q2
8 quarters
|
|
Similar funds
BV
Fairscale Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Fairscale Capital held 444 positions worth $167M, up 16% from $145M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 2.3%. Fairscale Capital opened 7 new positions and exited 3, leaving the 444-position portfolio largely intact.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 51% a quarter earlier, followed by Technology and Financials.
- Fairscale Capital's largest Q2 2026 buy was Calamos S&P 500 Structured Alt Protection ETF - June: 7,230 shares worth $200K.
- Fairscale Capital added most to Invesco QQQ Trust in Q2 2026, an estimated $566K increase.
- Fairscale Capital's biggest Q2 2026 reduction was Amgen, cutting an estimated $222K.
- Fairscale Capital fully exited Hologic in Q2 2026, selling an estimated $34.2K.
- Fairscale Capital's ten largest holdings make up 52% of its $167M portfolio in Q2 2026.
- Fairscale Capital opened 7 new positions and closed 3 in Q2 2026.
- Fairscale Capital's portfolio value rose 16% quarter-over-quarter to $167M.
Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.